| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | BOSTON SCIENTIFIC CORP. COMM | Jun 30, 2026 | |
| Buy | Boston Scientific Corporatio | Jun 5, 2026 | |
| Sell | Boston Scientific Corporatio | Jun 5, 2026 | |
| Sell | Boston Scientific Corporatio | Jun 4, 2026 | |
| Sell | BOSTON SCIENTIFIC CORP. COMM | Jun 2, 2026 | |
| Buy | Boston Scientific Corporatio | May 29, 2026 | |
| Buy | Boston Scientific Corporatio | May 19, 2026 | |
| Buy | Boston Scientific Corporatio | May 11, 2026 | |
| Buy | BOSTON SCIENTIFIC CORP. COMM | Apr 24, 2026 | |
| Buy | Boston Scientific Corporatio | Mar 27, 2026 |
This page tracks congressional stock trading activity in Boston Scientific Corporation (BSX) in the Healthcare sector. Disclosed Capitol has indexed 185 disclosed congressional trades involving BSX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 185 disclosed congressional trades in Boston Scientific Corporation (BSX) — 83:51 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 30, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jun 5, 2026 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| Jun 5, 2026 | Gilbert Cisneros | D | Sell | $1,001 - $15,000 |
| Jun 4, 2026 | John Boozman | R | Sell | $1,001 - $15,000 |
| Jun 2, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| May 29, 2026 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| May 19, 2026 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| May 11, 2026 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| Apr 24, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
Across the 185 disclosed congressional trades in Boston Scientific Corporation (BSX), members of Congress have reported 51 buys and 83 sells. The average 30-day alpha vs. the S&P 500 is -0.51%.
As of July 2026, Boston Scientific Corporation has 1,146 federal contract award records on file from USAspending.gov — most recently $100K from the Department of Veterans Affairs on 2026-07-22.
| Award date | Agency | Amount |
|---|---|---|
| 2026-07-22 | Department of Veterans Affairs | $100K |
| 2026-07-16 | Department of Veterans Affairs | $608K |
| 2026-07-02 | Department of Veterans Affairs | -$79K |
| 2026-07-02 | Department of Veterans Affairs | $52K |
| 2026-07-01 | Department of Veterans Affairs | $76K |
| 2026-06-29 | Department of Veterans Affairs | $125K |
| 2026-06-29 | Department of Veterans Affairs | $125K |
| 2026-06-15 | Department of Veterans Affairs | $305K |
| 2026-06-12 | Department of Veterans Affairs | $305K |
| 2026-05-29 | Department of Veterans Affairs | -$182K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Boston Scientific Corporation reported revenue of $20.07B and net income of $2.90B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $5.44B, net income $906.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.